Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Aripiprazole impurity 32, also known as Deschloroaripiprazole, is a chemical impurity associated with the antipsychotic agent Aripiprazole. This impurity is important for analytical characterization in pharmaceutical research and development, particularly in the assessment of drug purity and stability. Its presence can significantly impact the pharmacological profile and safety evaluation of Aripiprazole formulations. Therefore, it is essential in quality control processes within drug development and regulatory compliance. -
Drug Impurity
Haloperidol impurity 11 is a known impurity of the antipsychotic agent Haloperidol. Its chemical characterization is crucial for quality control in pharmaceutical formulations. This impurity can serve as a reference standard in analytical studies aimed at ensuring the purity and efficacy of Haloperidol-based medications. Research applications include stability testing, formulation development, and regulatory compliance assessments. -
Drug Impurity
Irinotecan impurity 52 is a significant impurity associated with Irinotecan, a chemotherapeutic agent targeting topoisomerase I. This compound is used in drug development and quality control to assess the purity of Irinotecan formulations. Its identification and quantification are crucial for ensuring the safety and efficacy of cancer treatment regimens involving Irinotecan. -
Drug Impurity
Tenofovir impurity 2, also known as (S)-Tenofovir disoproxil, serves as a chemical impurity of the antiviral drug Tenofovir. This compound is crucial for analytical and quality control applications in pharmaceutical research, particularly in the assessment of Tenofovir's purity. Its presence is important for understanding the overall safety and efficacy profiles of Tenofovir-based formulations. -
Drug Impurity
Ropinirole impurity 7, also known as SKF-96266, is a chemical impurity associated with the synthesis of Ropinirole. This compound serves as an analytical standard for quality control in pharmaceutical development, facilitating the detection and quantification of Ropinirole impurities. Its characterization is critical for ensuring the purity and safety of Ropinirole in clinical applications. -
Drug Impurity
Haloperidol impurity 12 is a known impurity associated with the antipsychotic agent Haloperidol, primarily identified through analytical methods in pharmaceutical research. This compound serves as a reference standard for the evaluation of drug purity and quality control in the synthesis of Haloperidol. Its characterization is essential for ensuring the safety and efficacy of Haloperidol formulations in clinical applications. -
Drug Impurity
Etoricoxib impurity 10 is identified as a significant impurity of the nonsteroidal anti-inflammatory drug Etoricoxib. This compound is utilized primarily in pharmaceutical research to assess the purity and quality of Etoricoxib formulations. Its presence can impact the safety and efficacy profile of drug products, making it relevant for regulatory compliance and analytical chemistry studies. -
Drug Impurity
Rosuvastatin impurity 44, also known as Rosuvastatin-Lactone Impurity, is a chemical entity related to the statin class of drugs, specifically acting as an impurity of Rosuvastatin. Its presence can have implications for drug quality and efficacy. This compound is essential for quality control and analytical studies in pharmaceutical research, particularly in the evaluation of Rosuvastatin formulations. -
Drug Impurity
Tenofovir impurity 5 is a degradation product of Tenofovir, a nucleoside reverse transcriptase inhibitor. This compound serves as an important reference standard in pharmaceutical development for assessing the purity and stability of Tenofovir formulations. It is essential for quality control and compliance in the manufacturing of antiretroviral drugs. -
Drug Impurity
Acebutolol impurity 2 is a known impurity associated with the beta-adrenergic antagonist Acebutolol. This compound is utilized primarily in pharmaceutical research to assess the purity and stability of Acebutolol formulations. Its identification and quantification are crucial for ensuring the safety and efficacy of beta-blocker therapies in clinical applications. -
Drug Impurity
Carvedilol impurity 4 is a known impurity of the beta-blocker carvedilol, primarily utilized in the assessment of drug quality and safety. This compound is relevant in pharmaceutical research and development, particularly in studies focusing on the characterization of drug formulations and the evaluation of potential effects of impurities on pharmacological activity. Its presence is critical for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Progesterone impurity 6, also known as 1-Dehydroprogesterone, is a chemical impurity associated with Progesterone synthesis. This compound may serve as a useful reference standard for the characterization and quantification of progesterone and its derivatives in pharmaceutical formulations. Its presence can influence drug activity and stability, making it relevant in studies concerning drug formulation and quality control. -
Drug Impurity
Tamsulosin impurity 4 is a known impurity associated with the pharmaceutical compound Tamsulosin. This chemical entity is primarily utilized in the assessment of drug purity and quality control in pharmaceutical research and development. Its presence is critical for ensuring compliance with regulatory standards in medication formulation, contributing to the overall safety and efficacy of Tamsulosin-based therapeutics. -
Drug Impurity
Sildenafil impurity 6 is a characterized impurity of Sildenafil, primarily utilized in purity assessment during drug development. This impurity serves as a critical reference standard for analytical studies, supporting quality control and compliance in pharmaceutical research. Its presence can influence the pharmacokinetic and pharmacodynamic profiles of the parent compound, making it an important focus in the evaluation of Sildenafil formulations. -
Drug Impurity
Paliperidone impurity 6, also known as 9-Keto risperidone, is a known impurity of the antipsychotic drug paliperidone. This compound may serve as a valuable reference standard for evaluating the purity and quality of paliperidone formulations. Its identification is important for ensuring the safety and efficacy of pharmaceutical products containing paliperidone in clinical and research settings. -
Drug Impurity
Haloperidol impurity 15, also known as Haloperidol Undecanoate, is a chemical impurity associated with Haloperidol. This compound is primarily studied for its role in assessing the purity of Haloperidol formulations. It serves as an essential tool in drug quality control and pharmacological research, facilitating comprehensive investigations into the effects of Haloperidol and its metabolites. -
Drug Impurity
Ramipril impurity 2 (ent-Ramipril) is a known impurity of the angiotensin-converting enzyme (ACE) inhibitor Ramipril. This compound is utilized primarily in drug characterization and quality control studies to assess the purity and stability of pharmaceutical preparations. Understanding this impurity is essential for ensuring the safety and efficacy of Ramipril and its formulations in clinical applications. -
Drug Impurity
Methylprednisolone acetate impurity 4 is a known impurity associated with the synthesis of Methylprednisolone acetate, a synthetic corticosteroid. This compound is relevant in the context of drug quality control and stability studies, assisting researchers in evaluating the purity of pharmaceutical formulations. Its analysis is critical for ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Tenofovir impurity 24 is a chemical impurity associated with the antiviral drug Tenofovir. It is primarily utilized in pharmaceutical research and quality control to assess the purity of Tenofovir formulations. The presence of such impurities is critical for ensuring drug safety, efficacy, and regulatory compliance. -
Drug Impurity
Quetiapine impurity 2, also known as Quetiapine carboxylate impurity, is a chemical impurity associated with the antipsychotic agent Quetiapine. This compound can serve as a critical reference standard in the analysis of pharmaceutical formulations, ensuring the purity and compliance of drug products. Its study is essential for understanding the implications of impurities on drug efficacy and safety in pharmaceutical research. -
Drug Impurity
Leflunomide impurity 8 is identified as 5-Methyl-N-(p-tolyl)isoxazole-4-carboxamide and serves as a drug impurity. This compound may be utilized in pharmacological studies and analytical chemistry to assess the purity and quality of leflunomide formulations. Its presence can impact the evaluation of drug safety and efficacy, making it a significant marker in drug development and quality control processes. -
Drug Impurity
Glipizide impurity 2, also known as Glipizide impurity A, is a known impurity associated with the antidiabetic agent Glipizide. This compound is essential for analytical development and quality control in pharmaceutical research, helping to ensure the purity and safety of Glipizide formulations. Its identification and quantification are critical in compliance with regulatory standards for drug manufacturing. -
Drug Impurity
Paliperidone impurity 11 is a defluorinated derivative of Paliperidone, serving as a key impurity in drug synthesis and quality control. This compound is utilized in the assessment of Paliperidone formulations to ensure compliance with pharmaceutical standards and regulations. Its characterization is essential in understanding the stability, efficacy, and safety of the final pharmaceutical product. -
Drug Impurity
Sildenafil Impurity 3 is a chemical byproduct associated with the phosphodiesterase type 5 (PDE5) inhibitor sildenafil. This impurity is crucial for quality control and safety assessments in pharmaceutical formulations of sildenafil. It serves as a reference standard in analytical chemistry for identifying and quantifying impurities during the development and testing of PDE5 inhibitors, ensuring regulatory compliance and product integrity. -
Drug Impurity
Clindamycin phosphate impurity 8 is a known impurity of clindamycin phosphate, affecting the overall quality and efficacy of formulations containing this antibiotic. Its presence can influence pharmacokinetics and pharmacodynamics, making it important in stability studies and quality control assessments. This compound is primarily utilized in the analysis of clindamycin phosphate formulations in pharmaceutical research and development. -
Drug Impurity
Azilsartan Impurity 30, also known as Azilsartan-13, is a chemical impurity associated with the antihypertensive agent Azilsartan. This compound is utilized primarily for analytical and quality control purposes in pharmaceutical research. It provides insight into the purity of Azilsartan and assists in the evaluation of formulation stability and efficacy. -
Drug Impurity
Testosterone impurity 6 is a notable impurity associated with Testosterone. This compound is critical for analytical studies in pharmaceutical research, particularly in the evaluation of drug purity and stability. Its presence can impact pharmacokinetic profiles and may influence the overall safety and efficacy of testosterone-derived therapies. Testing for this impurity is essential for ensuring compliance with regulatory standards in the development of hormone-related medications. -
Drug Impurity
Chlorthalidone impurity 4 is a known impurity associated with the thiazide diuretic chlorthalidone. It plays a significant role in pharmaceutical analysis, particularly in the assessment of drug quality and purity. This compound is utilized in regulatory settings to ensure compliance with guidelines for impurity levels in therapeutic formulations. Its characterization aids in understanding the stability and safety profiles of chlorthalidone-based medications. -
Drug Impurity
Everolimus impurity 16 is a known impurity of the mTOR inhibitor Everolimus. It is essential for analytical and quality control studies, particularly in the evaluation of Everolimus formulations. This compound can be used to assess the purity and stability of pharmaceutical preparations, providing crucial data for drug development and regulatory compliance. -
Drug Impurity
Abacavir impurity 9 is a drug impurity associated with Abacavir, an antiretroviral medication used in the treatment of HIV. This compound is important for quality control and analytical studies in pharmaceutical research, assisting in understanding the stability and degradation pathways of Abacavir. Its characterization is crucial for ensuring the safety and efficacy of formulations containing Abacavir. -
Drug Impurity
Allopurinol impurity 5 is a chemical impurity associated with the synthesis of Allopurinol, which primarily targets xanthine oxidase. This impurity can be utilized in pharmacokinetic and toxicological studies to assess the purity of Allopurinol formulations. Its analysis is critical for ensuring the quality and safety of pharmaceutical products containing Allopurinol. -
Drug Impurity
Buspirone Impurity 10 is a identified impurity of the anxiolytic compound buspirone, primarily associated with its synthesis and analytical evaluation. This compound serves as a reference standard for the characterization and quantification of impurities in pharmaceutical formulations. It is valuable for quality control and regulatory compliance in drug development and production processes. -
Drug Impurity
Trelagliptin impurity 2 is an impurity associated with Trelagliptin, a DPP-4 inhibitor. This compound serves as an essential reference for the identification and quantification of potential impurities in pharmaceutical formulations. It is particularly relevant for analytical studies focused on the characterization of drug purity and stability in drug development processes. -
Drug Impurity
Oxcarbazepine impurity 1 is a known impurity associated with the anticonvulsant drug Oxcarbazepine. This compound is utilized primarily in drug development and quality control settings, where assessing the presence and concentration of impurities is critical for ensuring compliance with regulatory standards. Research applications include analytical method development and safety evaluation of pharmaceutical formulations containing Oxcarbazepine. -
Drug Impurity
Doxycycline impurity 2 is a structural impurity associated with the antibiotic Doxycycline. Its presence may affect the purity profile of Doxycycline in pharmaceutical formulations. This compound serves as a reference standard for analytical purposes in drug development and quality control, ensuring that the levels of impurities are monitored in accordance with regulatory guidelines. -
Drug Impurity
Rosuvastatin impurity 25 calcium is a chemical impurity associated with Rosuvastatin calcium, a widely used statin for lowering cholesterol levels. It serves a critical role in analytical research, particularly in the evaluation of drug purity and safety. This impurity is essential for quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Rosuvastatin impurity 11 is identified as a chemical impurity associated with the pharmaceutical agent Rosuvastatin. This compound serves as a critical reference standard in the assessment of drug purity and quality control during pharmaceutical development. It is utilized in analytical method validation and regulatory submissions, ensuring compliance with safety and efficacy standards in the production of statin-based therapies. -
Drug Impurity
Candesartan impurity 32 is characterized as a drug impurity associated with candesartan synthesis. This compound is important for the quality control and analytical assessments of candesartan formulations. Its identification and quantification are crucial for ensuring the purity and safety of pharmaceutical products containing candesartan. -
Drug Impurity
Trazodone Impurity 5 Hydrochloride is a known impurity associated with the antidepressant Trazodone Hydrochloride. This compound is primarily utilized in pharmaceutical development and quality control studies to assess drug purity and compliance with regulatory standards. Its characterization aids in understanding the stability and safety profile of Trazodone formulations. -
Drug Impurity
Itraconazole impurity 7, also known as Itraconazole impurity B, is a known impurity of the antifungal agent Itraconazole. It serves as a critical substance for the evaluation of drug purity, safety, and efficacy in pharmaceutical research. This compound is utilized in analytical chemistry and quality control processes to ensure the integrity of Itraconazole formulations. -
Drug Impurity
Levomedetomidine is a drug impurity associated with the anesthetic agent dexmedetomidine. It serves as a valuable reference compound in the analysis and characterization of pharmaceutical formulations. Its presence may influence the pharmacological properties and safety profile of dexmedetomidine, making it important for quality control and regulatory compliance in drug development studies. Researchers can utilize levomedetomidine to better understand the implications of drug impurities in pharmacokinetics and efficacy. -
Drug Impurity
Telmisartan impurity 3 is a recognized impurity of the antihypertensive agent telmisartan. Its presence can be relevant in pharmaceutical development and quality control processes. This compound serves as a useful reference standard for analytical methods and ensures the integrity and safety of telmisartan formulations in research applications. -
Drug Impurity
Dexamethasone acetate impurity 1 is a known impurity of Dexamethasone acetate, a synthetic corticosteroid. This compound is primarily utilized in quality control and analytical chemistry to assess the purity of Dexamethasone acetate formulations. It serves as a key reference standard for studies on drug formulation and stability, ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Raloxifene impurity 4 is a chemical impurity associated with Raloxifene, a selective estrogen receptor modulator (SERM). It serves as a critical reference standard in the analysis of drug formulation and quality control processes. Researchers can utilize this impurity to assess the purity of Raloxifene in pharmaceutical preparations, ensuring compliance with regulatory standards and enhancing the safety and efficacy of therapeutic applications. -
Drug Impurity
Candesartan impurity 24 is a chemical impurity associated with Candesartan, an angiotensin II receptor antagonist. This compound is primarily utilized in research for the assessment of drug purity and the development of analytical methods for quality control. Its presence in formulations can significantly impact pharmacological efficacy and safety profiles, making it essential for studies focused on drug formulations and stability. -
Drug Impurity
Bupropion impurity 2 is a secondary metabolite associated with Bupropion, a widely used antidepressant and smoking cessation aid. This impurity may influence pharmacokinetic properties and can be utilized in studies assessing the quality and safety of pharmaceutical formulations. Its assessment is crucial for understanding the overall therapeutic profile of Bupropion and ensuring compliance with regulatory standards in drug development. -
Drug Impurity
Sertraline impurity 10 is a chemical impurity associated with the selective serotonin reuptake inhibitor (SSRI) sertraline. This impurity is relevant for analytical and quality control studies in pharmaceutical research, particularly in the assessment of sertraline's purity and stability. Its presence may impact the safety and efficacy profile of sertraline, making it essential for compliance with regulatory standards in drug development. -
Drug Impurity
Tranexamic acid impurity 1 is a chemical impurity associated with Tranexamic acid, a synthetic derivative of lysine that inhibits fibrinolysis through the blockade of plasminogen activation. This compound serves as a critical reference standard for quality control and analytical validation in pharmaceutical development. Its characterization is essential for ensuring the purity and safety of Tranexamic acid formulations used in various medical applications. -
Drug Impurity
Baroxavir impurity 17 is a known impurity of Baroxavir, a drug primarily targeting viral RNA polymerases. This compound serves as an important reference standard in analytical chemistry, facilitating the assessment of purity and quality in Baroxavir formulations. Its characterization is crucial for ensuring compliance with regulatory standards in pharmaceutical research and development. -
Drug Impurity
Lopinavir impurity 7 is a characterized impurity of the antiviral compound Lopinavir, which primarily targets the HIV protease enzyme. This impurity is significant for analytical studies and quality control in pharmaceutical research, ensuring the integrity and safety of Lopinavir formulations. Its presence can influence the pharmacokinetic and pharmacodynamic properties of the parent compound, making it a valuable reference for investigators focused on drug development and formulation optimization.
